CARRIE DANIELS: Open Payments
NPI 1104225739 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 14 payments from 7 companies in 2025. Trend: 2023 $661 · 2024 $199 · 2025 $370
Food & beverage: $351Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $151 |
| Corcept Therapeutics | 1 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Abbott Laboratories | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Medtronic, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Korlym, REXULTI, Wegovy, FREESTYLE LIBRE 3, FARXIGA, MVP, JARDIANCE, Rybelsus.
Industry payments across IN — which companies pay providers there.
